A Six Part Series
by Don Margolis, Founder of the Repair Stem Cell Institute – http://repairstemcells.org
A Grim Fairy Tale – Part 6
There are six reasons why embryonic stem cells will never make it out of the lab and into the bodies of sick Americans.
Reason 6: Follow the Money, not the Science
There is just no way that anyone can make money, in the long run, from the disaster known as embryonics. Sure, in the short run there can be some old boy network exchanges of cash between funders and research facility executives, but once the word got out that embryonic stem cells can cause cancer or destroy immune systems, the money train was diverted, as seen by Geron (GERN) stock: $75 in 2000, $1.95 in 2008 until Wall Street, seeing Obama about to win, started its own profiteering, ripping off investors to the tune of $43,000,000. See “Geron Marches On” in our March 5 Special Newsletter:
The dead end research of embryonics protects the huge profit margins of Big Medicine’s profitable drugs, no matter how deadly (Vioxx et al); profitable medical machines, no matter how toxic (drug eluding stents); profitable tests no matter the risk (mammograms); and profitable hospitalizations, no matter how useless (too numerous to mention). Support for the real cure of RSC could ravage those profits. Small wonder that the money and their controlled media have been attacking the only stem cells that actually work, calling RSC “snake oil.”
As Sharon Begley points out in her recent Newsweek article, “Doctors have long resisted having science guide their practice.” Add to that the list of science-resisting profiteers: pharmaceutical companies, medical device makers, health insurance companies and health management organizations, and it becomes much clearer why ESCs, which will never cure anything and affect profits, have been heavily promoted, while RSCs, which can diminish the current outrageous profits, have been heavily disparaged. Just another reason why the American Medical System has been proven the worst in the developed world. See “Why Not the Best” at: